Pay for performance for hospitals.


Journal

The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747

Informations de publication

Date de publication:
05 Jul 2019
Historique:
pubmed: 6 7 2019
medline: 29 9 2019
entrez: 6 7 2019
Statut: epublish

Résumé

Pay-for-Performance (P4P) is a payment model that rewards health care providers for meeting pre-defined targets for quality indicators or efficacy parameters to increase the quality or efficacy of care. Our objective was to assess the impact of P4P for in-hospital delivered health care on the quality of care, resource use and equity. Our objective was not only to answer the question whether P4P works in general (simple perspective) but to provide a comprehensive and detailed overview of P4P with a focus on analyzing the intervention components, the context factors and their interrelation (more complex perspective). We searched CENTRAL, MEDLINE, Embase, three other databases and two trial registers on 27 June 2018. In addition, we searched conference proceedings, gray literature and web pages of relevant health care institutions, contacted experts in the field, conducted cited reference searches and performed cross-checks of included references and systematic reviews on the same topic. We included randomized trials, cluster randomized trials, non-randomized clustered trials, controlled before-after studies, interrupted time series and repeated measures studies that analyzed hospitals, hospital units or groups of hospitals and that compared any kind of P4P to a basic payment scheme (e.g. capitation) without P4P. Studies had to analyze at least one of the following outcomes to be eligible: patient outcomes; quality of care; utilization, coverage or access; resource use, costs and cost shifting; healthcare provider outcomes; equity; adverse effects or harms. Two review authors independently screened all citations for inclusion, extracted study data and assessed risk of bias for each included study. Study characteristics were extracted by one reviewer and verified by a second.We did not perform meta-analysis because the included studies were too heterogenous regarding hospital characteristics, the design of the P4P programs and study design. Instead we present a structured narrative synthesis considering the complexity as well as the context/setting of the intervention. We assessed the certainty of evidence using the GRADE approach and present the results narratively in 'Summary of findings' tables. We included 27 studies (20 CBA, 7 ITS) on six different P4P programs. Studies analyzed between 10 and 4267 centers. All P4P programs targeted acute or emergency physical conditions and compared a capitation-based payment scheme without P4P to the same capitation-based payment scheme combined with a P4P add-on. Two P4P program used rewards or penalties; one used first rewards and than penalties; two used penalties only and one used rewards only. Four P4P programs were established and evaluated in the USA, one in England and one in France.Most studies showed no difference or a very small effect in favor of the P4P program. The impact of each P4P program was as follows.Premier Hospital Quality Incentive Demonstration Program: It is uncertain whether this program, which used rewards for some hospitals and penalties for others, has an impact on mortality, adverse clinical events, quality of care, equity or resource use as the certainty of the evidence was very low.Value-Based Purchasing Program: It is uncertain whether this program, which used rewards for some hospitals and penalties for others, has an impact on mortality, adverse clinical events or quality of care as the certainty of the evidence was very low. Equity and resource use outcomes were not reported in the studies, which evaluated this program.Non-payment for Hospital-Acquired Conditions Program: It is uncertain whether this penalty-based program has an impact on adverse clinical events as the certainty of the evidence was very low. Mortality, quality of care, equity and resource use outcomes were not reported in the studies, which evaluated this program.Hospital Readmissions Reduction Program: None of the studies that examined this penalty-based program reported mortality, adverse clinical events, quality of care (process quality score), equity or resource use outcomes.Advancing Quality Program: It is uncertain whether this reward-/penalty-based program has an impact on mortality as the certainty of the evidence was very low. Adverse clinical events, quality of care, equity and resource use outcomes were not reported in any study.Financial Incentive to Quality Improvement Program: It is uncertain whether this reward-based program has an impact on quality of care, as the certainty of the evidence was very low. Mortality, adverse clinical events, equity and resource use outcomes were not reported in any study.Subgroup analysis (analysis of modifying design and context factors)Analysis of P4P design factors provides some hints that non-payments compared to additional payments and payments for quality attainment (e.g. falling below specified mortality threshold) compared to quality improvement (e.g. reduction of mortality by specified percent points within one year) may have a stronger impact on performance. It is uncertain whether P4P, compared to capitation-based payments without P4P for hospitals, has an impact on patient outcomes, quality of care, equity or resource use as the certainty of the evidence was very low (or we found no studies on the outcome) for all P4P programs. The effects on patient outcomes of P4P in hospitals were at most small, regardless of design factors and context/setting. It seems that with additional payments only small short-term but non-sustainable effects can be achieved. Non-payments seem to be slightly more effective than bonuses and payments for quality attainment seem to be slightly more effective than payments for quality improvement.

Sections du résumé

BACKGROUND BACKGROUND
Pay-for-Performance (P4P) is a payment model that rewards health care providers for meeting pre-defined targets for quality indicators or efficacy parameters to increase the quality or efficacy of care.
OBJECTIVES OBJECTIVE
Our objective was to assess the impact of P4P for in-hospital delivered health care on the quality of care, resource use and equity. Our objective was not only to answer the question whether P4P works in general (simple perspective) but to provide a comprehensive and detailed overview of P4P with a focus on analyzing the intervention components, the context factors and their interrelation (more complex perspective).
SEARCH METHODS METHODS
We searched CENTRAL, MEDLINE, Embase, three other databases and two trial registers on 27 June 2018. In addition, we searched conference proceedings, gray literature and web pages of relevant health care institutions, contacted experts in the field, conducted cited reference searches and performed cross-checks of included references and systematic reviews on the same topic.
SELECTION CRITERIA METHODS
We included randomized trials, cluster randomized trials, non-randomized clustered trials, controlled before-after studies, interrupted time series and repeated measures studies that analyzed hospitals, hospital units or groups of hospitals and that compared any kind of P4P to a basic payment scheme (e.g. capitation) without P4P. Studies had to analyze at least one of the following outcomes to be eligible: patient outcomes; quality of care; utilization, coverage or access; resource use, costs and cost shifting; healthcare provider outcomes; equity; adverse effects or harms.
DATA COLLECTION AND ANALYSIS METHODS
Two review authors independently screened all citations for inclusion, extracted study data and assessed risk of bias for each included study. Study characteristics were extracted by one reviewer and verified by a second.We did not perform meta-analysis because the included studies were too heterogenous regarding hospital characteristics, the design of the P4P programs and study design. Instead we present a structured narrative synthesis considering the complexity as well as the context/setting of the intervention. We assessed the certainty of evidence using the GRADE approach and present the results narratively in 'Summary of findings' tables.
MAIN RESULTS RESULTS
We included 27 studies (20 CBA, 7 ITS) on six different P4P programs. Studies analyzed between 10 and 4267 centers. All P4P programs targeted acute or emergency physical conditions and compared a capitation-based payment scheme without P4P to the same capitation-based payment scheme combined with a P4P add-on. Two P4P program used rewards or penalties; one used first rewards and than penalties; two used penalties only and one used rewards only. Four P4P programs were established and evaluated in the USA, one in England and one in France.Most studies showed no difference or a very small effect in favor of the P4P program. The impact of each P4P program was as follows.Premier Hospital Quality Incentive Demonstration Program: It is uncertain whether this program, which used rewards for some hospitals and penalties for others, has an impact on mortality, adverse clinical events, quality of care, equity or resource use as the certainty of the evidence was very low.Value-Based Purchasing Program: It is uncertain whether this program, which used rewards for some hospitals and penalties for others, has an impact on mortality, adverse clinical events or quality of care as the certainty of the evidence was very low. Equity and resource use outcomes were not reported in the studies, which evaluated this program.Non-payment for Hospital-Acquired Conditions Program: It is uncertain whether this penalty-based program has an impact on adverse clinical events as the certainty of the evidence was very low. Mortality, quality of care, equity and resource use outcomes were not reported in the studies, which evaluated this program.Hospital Readmissions Reduction Program: None of the studies that examined this penalty-based program reported mortality, adverse clinical events, quality of care (process quality score), equity or resource use outcomes.Advancing Quality Program: It is uncertain whether this reward-/penalty-based program has an impact on mortality as the certainty of the evidence was very low. Adverse clinical events, quality of care, equity and resource use outcomes were not reported in any study.Financial Incentive to Quality Improvement Program: It is uncertain whether this reward-based program has an impact on quality of care, as the certainty of the evidence was very low. Mortality, adverse clinical events, equity and resource use outcomes were not reported in any study.Subgroup analysis (analysis of modifying design and context factors)Analysis of P4P design factors provides some hints that non-payments compared to additional payments and payments for quality attainment (e.g. falling below specified mortality threshold) compared to quality improvement (e.g. reduction of mortality by specified percent points within one year) may have a stronger impact on performance.
AUTHORS' CONCLUSIONS CONCLUSIONS
It is uncertain whether P4P, compared to capitation-based payments without P4P for hospitals, has an impact on patient outcomes, quality of care, equity or resource use as the certainty of the evidence was very low (or we found no studies on the outcome) for all P4P programs. The effects on patient outcomes of P4P in hospitals were at most small, regardless of design factors and context/setting. It seems that with additional payments only small short-term but non-sustainable effects can be achieved. Non-payments seem to be slightly more effective than bonuses and payments for quality attainment seem to be slightly more effective than payments for quality improvement.

Identifiants

pubmed: 31276606
doi: 10.1002/14651858.CD011156.pub2
pmc: PMC6611555
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

CD011156

Références

Health Aff (Millwood). 2011 Apr;30(4):690-8
pubmed: 21471490
Am J Manag Care. 2014 Oct 01;20(10):e479-86
pubmed: 25414986
Ann Intern Med. 2006 Aug 15;145(4):265-72
pubmed: 16908917
N Engl J Med. 2017 Jun 15;376(24):2358-2366
pubmed: 28614675
Int J Health Plann Manage. 1995 Jan-Mar;10(1):23-45
pubmed: 10142120
N Engl J Med. 2012 Nov 8;367(19):1821-8
pubmed: 23134382
Jt Comm J Qual Patient Saf. 2015 Jun;41(6):257-63
pubmed: 25990891
Jt Comm J Qual Patient Saf. 2011 Apr;37(4):184-92, 145
pubmed: 21500719
Ann Intern Med. 2010 Sep 7;153(5):299-306
pubmed: 20820039
N Engl J Med. 2007 Feb 1;356(5):486-96
pubmed: 17259444
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Health Aff (Millwood). 2015 Jun;34(6):907-15
pubmed: 26056194
Infect Control Hosp Epidemiol. 2017 Jul;38(7):817-822
pubmed: 28487001
J Healthc Qual. 2006 Mar-Apr;28(2):36-44, 51
pubmed: 16749298
Hosp Top. 2016;94(1):8-14
pubmed: 26980202
JAMA. 2007 Jun 6;297(21):2373-80
pubmed: 17551130
Med Care. 2017 May;55(5):447-455
pubmed: 27922910
J Health Econ. 1991;10(4):411-32
pubmed: 10117012
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
BMJ. 2004 Apr 24;328(7446):969-70
pubmed: 15105304
Cochrane Database Syst Rev. 2000;(3):CD002215
pubmed: 10908531
Health Policy Plan. 2016 Feb;31(1):83-90
pubmed: 25944704
N Engl J Med. 2012 Oct 11;367(15):1428-37
pubmed: 23050526
J Bone Joint Surg Am. 2008 Jun;90(6):1240-3
pubmed: 18519316
Eur J Health Econ. 2016 May;17(4):435-42
pubmed: 25860814
Health Serv Res. 2009 Jun;44(3):821-42
pubmed: 19674427
Health Serv Res. 2015 Feb;50(1):81-97
pubmed: 25040485
Health Care Law Mon. 2011 Feb;2011(2):2-9
pubmed: 21400963
N Engl J Med. 2012 Nov 8;367(19):1852-3
pubmed: 23134388
Find Brief. 2010 Dec;13(7):1-2
pubmed: 21560794
Health Serv Res. 2010 Feb;45(1):6-23
pubmed: 19840137
Qual Health Care. 2000 Dec;9(4):210-5
pubmed: 11101705
N Engl J Med. 2014 Aug 7;371(6):540-8
pubmed: 25099578
Am J Med Qual. 2009 Jan-Feb;24(1):19-28
pubmed: 19073941
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Med Care Res Rev. 2006 Feb;63(1 Suppl):29S-48S
pubmed: 16688923
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD007899
pubmed: 22336833
BMJ. 2007 Mar 3;334(7591):455-9
pubmed: 17332585
Clin Infect Dis. 2012 Oct;55(7):923-9
pubmed: 22700826
Infect Control Hosp Epidemiol. 2015 Aug;36(8):871-7
pubmed: 25906824
BMC Health Serv Res. 2010 Aug 23;10:247
pubmed: 20731816
J Health Econ. 1986 Jun;5(2):129-51
pubmed: 10287223
J Health Econ. 1996 Jun;15(3):257-77
pubmed: 10159442
Health Policy. 1994 May;28(2):89-132
pubmed: 10171936
Perspect Health Inf Manag. 2008;5:14
pubmed: 18927601
N Engl J Med. 2016 Apr 21;374(16):1543-51
pubmed: 26910198
Health Serv Res. 2012 Aug;47(4):1418-36
pubmed: 22417137
Health Serv Res. 2014 Apr;49(2):568-87
pubmed: 23909992
Trans Am Clin Climatol Assoc. 2007;118:263-72
pubmed: 18528509
Ann Surg. 2014 Apr;259(4):677-81
pubmed: 24368657
J Clin Epidemiol. 2013 Nov;66(11):1209-14
pubmed: 23953085
J Healthc Qual. 2010 Jan-Feb;32(1):42-50; quiz 50
pubmed: 20151591
Ann Surg. 2017 Oct;266(4):617-624
pubmed: 28657948
Health Serv Res. 2011 Jun;46(3):712-28
pubmed: 21210796
Med Care. 2017 Nov;55(11):924-930
pubmed: 29028756
Med Care. 2016 Feb;54(2):162-71
pubmed: 26761728
Health Policy. 2014 Apr;115(2-3):165-71
pubmed: 24361201
Trials. 2013 Jan 12;14:15
pubmed: 23311722
Med Care Res Rev. 2017 Feb;74(1):3-78
pubmed: 26743502
Implement Sci. 2015 Jan 13;10:9
pubmed: 25582091
Med Care. 2016 May;54(5):512-8
pubmed: 27078824
Praxis (Bern 1994). 2009 Dec 16;98(25):1499-509
pubmed: 20013686
Health Policy. 2013 May;110(2-3):115-30
pubmed: 23380190
BMJ. 2016 May 09;353:i2214
pubmed: 27160187
JAMA Intern Med. 2015 Mar;175(3):347-54
pubmed: 25559166
J Gen Intern Med. 2016 Apr;31 Suppl 1:61-9
pubmed: 26951276
Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):727-34
pubmed: 25160840
Health Econ. 2017 Aug;26(8):1037-1051
pubmed: 27416886
J Healthc Manag. 2007 Mar-Apr;52(2):95-107; discussion 107-8
pubmed: 17447537
Infect Control Hosp Epidemiol. 2015 Jun;36(6):649-55
pubmed: 25732568
N Engl J Med. 2010 Dec 23;363(26):2477-81
pubmed: 21142528
Am J Public Health. 2006 Mar;96(3):538-46
pubmed: 16449581
Health Aff (Millwood). 2012 Dec;31(12):2649-58
pubmed: 23213149
Int J Qual Health Care. 2000 Apr;12(2):133-42
pubmed: 10830670
JAMA. 2016 Dec 27;316(24):2647-2656
pubmed: 28027367
Int J Qual Health Care. 2017 Oct 01;29(6):833-837
pubmed: 29024997
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Ann Intern Med. 2017 Mar 07;166(5):341-353
pubmed: 28114600
Health Serv Res. 2012 Dec;47(6):2118-36
pubmed: 23088391
N Engl J Med. 2012 Apr 26;366(17):1606-15
pubmed: 22455751
PLoS Med. 2009 Aug;6(8):e1000086
pubmed: 19668360

Auteurs

Tim Mathes (T)

Institute for Research in Operative Medicine (IFOM) - Department for Evidence-based Health Services Research, University Witten/Herdecke, Ostmerheimer Str. 200 (House 38), Cologne, Germany, 51109.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH